Physiologically Based Pharmacokinetic (PBPK) Modeling of Meropenem Pharmacokinetics in Healthy and Renally Impaired Adults

被引：0
|
作者：
Castleman, Andrew [1 ]
Owen, Joel S. [1 ]
机构：
[1] Union Univ, Sch Pharm, Jackson, TN 38305 USA
来源：
JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS | 2016年 / 43卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
M-05
引用
收藏
页码：S13 / S13
页数：1
相关论文
共 50 条
  • [31] Physiologically Based Pharmacokinetic Modeling of Meropenem in Preterm and Term Infants
    Samit Ganguly
    Andrea N. Edginton
    Jacqueline G. Gerhart
    Michael Cohen-Wolkowiez
    Rachel G. Greenberg
    Daniel Gonzalez
    Clinical Pharmacokinetics, 2021, 60 : 1591 - 1604
  • [32] A Comprehensive Whole-Body Physiologically Based Pharmacokinetic Drug–Drug–Gene Interaction Model of Metformin and Cimetidine in Healthy Adults and Renally Impaired Individuals
    Nina Hanke
    Denise Türk
    Dominik Selzer
    Naoki Ishiguro
    Thomas Ebner
    Sabrina Wiebe
    Fabian Müller
    Peter Stopfer
    Valerie Nock
    Thorsten Lehr
    Clinical Pharmacokinetics, 2020, 59 : 1419 - 1431
  • [33] Predictive Performance of Physiologically Based Pharmacokinetic and Population Pharmacokinetic Modeling of Renally Cleared Drugs in Children
    Zhou, W.
    Johnson, T. N.
    Xu, H.
    Cheung, S. Y. A.
    Bui, K. H.
    Li, J.
    Al-Huniti, N.
    Zhou, D.
    CPT-PHARMACOMETRICS & SYSTEMS PHARMACOLOGY, 2016, 5 (09): : 475 - 483
  • [34] Physiologically based pharmacokinetic (PBPK) modeling and simulation in drug discovery and development
    Shaik, Abdul Naveed
    Khan, Ansar Ali
    ADMET AND DMPK, 2019, 7 (01): : 1 - 3
  • [35] Physiologically based pharmacokinetic (PBPK) modeling and simulation: Applications in lead optimization
    Peters, Sheila Annie
    Ungell, Anna-Lena
    Dolgos, Hugues
    CURRENT OPINION IN DRUG DISCOVERY & DEVELOPMENT, 2009, 12 (04) : 509 - 518
  • [36] Pharmacokinetic study of memantine in healthy and renally impaired subjects
    Periclou, A
    Ventura, D
    Rao, N
    Abramowitz, W
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2006, 79 (01) : 134 - 143
  • [37] Physiologically based pharmacokinetic (PBPK) modeling of perfluorohexane sulfonate (PFHxS) in humans
    Sweeney, Lisa M.
    REGULATORY TOXICOLOGY AND PHARMACOLOGY, 2022, 129
  • [38] Physiologically Based Pharmacokinetic (PBPK) Modeling of Metabolic Pathways of Bromochloromethane in Rats
    Cuello, W. S.
    Janes, T. A. T.
    Jessee, J. M.
    Venecek, M. A.
    Sawyer, M. E.
    Eklund, C. R.
    Evans, M. V.
    JOURNAL OF TOXICOLOGY, 2012, 2012
  • [39] PREDICTIVE PERFORMANCE OF PHYSIOLOGICALLY BASED PHARMACOKINETIC (PBPK) MODELING OF SUFENTANIL IN CHILDREN
    Zhou, W.
    Johnson, T.
    Bui, K.
    Cheung, A.
    Li, J.
    Xu, H.
    Al-Huniti, N.
    Zhou, D.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2017, 101 (S1) : S94 - S94
  • [40] Physiologically based pharmacokinetic (PBPK) modeling of RNAi therapeutics: Opportunities and challenges
    Fairman, Kiara
    Li, Miao
    Ning, Baitang
    Lumen, Annie
    BIOCHEMICAL PHARMACOLOGY, 2021, 189
12345